Preliminary Scientific Programme

Wednesday, 22 Septemer 2021

15.00 – 19.00

Arrivals and Registration

19.00

Reception and Welcome

Thursday, 23 September 2021

Morning programme: Plenary Sessions and Abstract Presentations

 

 

Time

Speaker

Title

08.45 - 09.00

S. Konstantinides, DE/GR;
M. V. Huisman, NL

Introduction to the 5th VTE Spring School

09.00 – 09.40

S. Barco, CH; S. Brækkan, NO

Venous thromboembolism: Global trends in incidence and mortality

09.40 - 10.20

M. V. Huisman, NL; Comments: P. Prandoni, IT

Treating venous thromboembolism in patients with cancer: How can the recent trials change our clinical practice?

10.20 – 10.50

 

Coffee break

10.50 – 11.30

O. Sanchez, FR

Preventing, diagnosing and treating venous thromboembolism in the COVID-19 pandemic

11.30 – 12.20

M. Righini, CH; F. Ní Ainle, IE

Diagnostic strategies for suspected pulmonary embolism: Recent progress, also in specific vulnerable populations

12.20 – 13.30

 

Abstract Session I 

13.30 – 16.30

 

Lunch and learn (informal exchange with the experts), followed by afternoon break

Afternoon programme: Breakout Parallel Workshops

 

 

16.30 – 17.15

 

Workshops I/II: Hands-on tutorials

17.15 – 18.00

 

Workshops III/IV: Career and academic trial tutorials

18.00 – 18.30

 

Coffee break

18.30 – 19.15

 

Workshops V/VI

19.15 - 20.00

 

Workshops VII/VIII

Friday, 24 Septemeber 2021

Morning programme: Plenary Sessions and Abstract Presentations

 

 

Time

Speaker

Title

08.30 – 09.10

L. Meijboom, NL;
M. Sproule, UK

The radiologist’s role in diagnosing acute and chronic thromboembolic disease

09.10 – 09.50

C. Becattini, IT; D. Jiménez, ES

Risk stratification of pulmonary embolism: Which are the remaining grey zones?

09.50 - 10.30

N. Meneveau, FR

Treatment of acute right heart failure: State of the art 2021

10.30 – 11.00

 

Coffee break

11.00 – 11.40

A. Sharp, UK

Catheter interventions for acute pulmonary embolism: Current and emerging options

11.40 – 12.20

M. Levi, NL

Thrombosis and coagulopathy in COVID-19: What have we learned at the bench and bedside? What will remain useful in the post COVID era?

12:20 – 13.30

 

Abstract Session II

13.30 - 16.30

 

Lunch and learn (informal exchange with the experts), followed by afternoon break

Afternoon programme: Breakout Parallel Workshops

 

 

16.30 – 17.15

 

Workshops VII/VIII

17.15 – 18.00

 

Workshops V/VI

18.00 – 18.30

 

Coffee break

18.30 – 19.15

 

Workshops IX/X

19.15 - 20.00

 

Workshops XI/XII

Saturday, 25 September 2021

Morning programme: Plenary Sessions and Young Investigator Awards

 

 

Time

Speaker

Title

08.30 – 09.10

F.A. Klok, NL

From acute to chronic thromboembolic disease: Defining and predicting the “Post-PE Syndrome”

09.10 – 09.50

G. Giannakoulas, GR

How do I follow my patients after acute pulmonary embolism?

09.50 – 10.30

P. Pruszczyk, PL

Chronic thromboembolic disease: A growing role for the interventional cardiologist?

10.30 – 11.00

 

Coffee break

11.00 – 11.40

S. Konstantinides, DE/GR

The next generation of anticoagulants: Going beyond factor IIa and factor Xa inhibition

11.40 – 12.00

 

Announcement of Young Investigator Award Winners

12.00 - 15.00

 

Lunch and learn (informal exchange with the experts), followed by afternoon break

Afternoon programme: Breakout Parallel Workshops

 

 

15.00 – 15.45

 

Workshops I/II: Hands-on tutorials

15.45 – 16.30

 

Workshops III/IV: Career and academic trial tutorials

16.30 - 17.00

 

Coffee break

17.00 - 17.45

 

Workshops XI/XII

17.45 - 18.30

 

Workshops IX/X

Closing Session

 

 

18.30 – 19.30

All

Conclusions, ideas for the 6th Euro Spring School 2023

20.00 – 23.00

 

Farewell Dinner

Sunday, 26 September 2021

Departures

List of breakout afternoon sessions with case-based interactive workshops:

(Throughout the School, each participant will be able to choose the day and session, and attend all 12 workshops)

 

 

Workshop

Moderator

Title

W-I

S. Barco, CH; L. Hobohm, DE; B. Stefanovic, RS

Hands-on tutorial: Cardiac and vascular ultrasound

W-II

M. D’Alto, IT

Hands-on tutorial: Right heart catheterization

W-III

C. Nourse, DE

Opportunities for supporting early career physician-scientists

W-IV

D. Becker, DE; N. Martin, DE

Academic clinical trials: From the first idea to the first enrolled patient

W-V

M. Kozak, SI; A. Sharp, UK

How would you treat this patient with intermediate-risk PE? Thrombolysis? Interventional treatment? Heparin alone?

W-VI

E. Campello, IT; F. Ní Ainle, IE

Tough calls in anticoagulation: Selecting candidates for extended treatment, managing fragile patients

W-VII

M. Huisman, NL; M. Lankeit, DE

My patient with “low-risk” PE: Shall I send him/her home as fast as possible? Or perhaps keep in the hospital a few days, just to be sure?

W-VIII

L. Bertoletti, FR; M. Sproule, UK

Acute pulmonary embolism, some months later - or was it pre-existing CTEPH?

W-IX

C. Becattini, IT; F. A. Klok, NL; P. Prandoni, IT

How I diagnose and treat thrombosis in atypical sites

W-X

C. Baumgartner, CH; K. Schreiber, DK

Immunothrombosis: What does it mean for the scientist, what for the clinician?

W-XI

C. Tromeur, FR; S. Konstantinides, DE/GR

The 'red side' of anticoagulation: Assessing bleeding risk, managing bleeding emergencies

W-XII

E. Vicaut, FR; L. Valerio, DE

The right study for the right question: Understanding the statistics of clinical trials and epidemiological studies

DOWNLOAD